West Pharmaceutical Services (NYSE:WST) to Buyback $1.00 billion in Outstanding Shares
West Pharmaceutical Services starts a $1 billion stock buyback program after fully using the previous one and declares a quarterly dividend of $0.22 per share.
- On February 17, 2026, West Pharmaceutical Services, Inc. authorized a $1 billion share repurchase program, announced from Exton, Pennsylvania.
- With the prior program exhausted, the Board of Directors designed the new share repurchase program to have no expiration and no obligation to acquire shares.
- The Company said it may repurchase shares on the open market or through negotiated transactions, with timing and amounts depending on stock price, economic and market conditions.
- On February 16, 2026, the Board of Directors of West Pharmaceutical Services, Inc. declared a $0.22 per-share dividend, payable on May 6, 2026 to record holders on April 29, 2026.
- Traded on the NYSE and included in the Standard & Poor's 500 index, West Pharmaceutical Services, Inc. employs over 10,000 team members and delivers over 41 billion components and devices each year.
17 Articles
17 Articles
West Pharmaceutical Services (NYSE:WST) to Buyback $1.00 billion in Outstanding Shares
West Pharmaceutical Services (NYSE:WST - Get Free Report) announced that its board has initiated a share buyback program on Tuesday, February 17th, RTT News reports. The company plans to buyback $1.00 billion in outstanding shares. This buyback authorization allows the medical instruments supplier to purchase up to 5.6% of its stock through open market purchases. Stock buyback programs are often an indication that the company's leadership believ…
West Announces Quarterly Dividend and Share Repurchase Program
EXTON, Pa., Feb. 17, 2026 /PRNewswire/ -- On February 16, 2026, the Board of Directors of West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, declared its regular quarterly dividend of $0.22 per…
Coverage Details
Bias Distribution
- 55% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium











